These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19564153)

  • 1. Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors.
    Kloss A; Meiners S; Ludwig A; Dahlmann B
    Cardiovasc Res; 2010 Jan; 85(2):367-75. PubMed ID: 19564153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132.
    Crawford LJ; Walker B; Ovaa H; Chauhan D; Anderson KC; Morris TC; Irvine AE
    Cancer Res; 2006 Jun; 66(12):6379-86. PubMed ID: 16778216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib.
    Berkers CR; Verdoes M; Lichtman E; Fiebiger E; Kessler BM; Anderson KC; Ploegh HL; Ovaa H; Galardy PJ
    Nat Methods; 2005 May; 2(5):357-62. PubMed ID: 15846363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status.
    Matondo M; Bousquet-Dubouch MP; Gallay N; Uttenweiler-Joseph S; Recher C; Payrastre B; Manenti S; Monsarrat B; Burlet-Schiltz O
    Leuk Res; 2010 Apr; 34(4):498-506. PubMed ID: 19811823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction.
    Supinski GS; Vanags J; Callahan LA
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L994-L1001. PubMed ID: 19376888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proteasome inhibitors with different chemical structures on the ubiquitin-proteasome system in vitro.
    Csizmadia V; Csizmadia E; Silverman L; Simpson C; Raczynski A; O'Brien L; Gallacher M; Cardoza K; Kadambi VJ; Fedyk ER; Alden CL
    Vet Pathol; 2010 Mar; 47(2):358-67. PubMed ID: 20124009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.
    Llobet D; Eritja N; Encinas M; Sorolla A; Yeramian A; Schoenenberger JA; Llombart-Cussac A; Marti RM; Matias-Guiu X; Dolcet X
    Anticancer Drugs; 2008 Feb; 19(2):115-24. PubMed ID: 18176107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-high throughput method of measuring proteasome inhibition in vitro and in cultured cells.
    Keyomarsi K; Efuet ET; Bui TN
    Cell Biol Toxicol; 2011 Apr; 27(2):123-31. PubMed ID: 20853140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.
    Saulle E; Petronelli A; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Cognetti F; Humphreys R; Peschle C; Testa U
    Apoptosis; 2007 Apr; 12(4):635-55. PubMed ID: 17252198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocyte-Damaging Effects and Binding Kinetics of Boronic Acid and Epoxyketone Proteasomal-Targeted Drugs.
    Hasinoff BB; Patel D
    Cardiovasc Toxicol; 2018 Dec; 18(6):557-568. PubMed ID: 29951728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
    Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
    Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
    Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD
    J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.
    Yerlikaya A; Erin N
    Int J Mol Med; 2008 Dec; 22(6):817-23. PubMed ID: 19020781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel proteasome inhibitors to overcome bortezomib resistance.
    Ruschak AM; Slassi M; Kay LE; Schimmer AD
    J Natl Cancer Inst; 2011 Jul; 103(13):1007-17. PubMed ID: 21606441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.
    Raaben M; Posthuma CC; Verheije MH; te Lintelo EG; Kikkert M; Drijfhout JW; Snijder EJ; Rottier PJ; de Haan CA
    J Virol; 2010 Aug; 84(15):7869-79. PubMed ID: 20484504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a proteasome in Pneumocystis carinii and its modulation by specific proteasome inhibitors.
    Tronconi E; Mazza F; Valerio A; Rinaudo MT; Piccinini M; Anselmino A; Cargnel A; Atzori C
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S142-3. PubMed ID: 17169035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proteasome inhibitor].
    Yamamura M; Hirai T; Yamaguchi Y
    Nihon Rinsho; 2010 Jun; 68(6):1079-84. PubMed ID: 20535959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition: mechanism of action.
    DeMartino GN
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S5-9. PubMed ID: 19791423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the specificity and activity profiles of the proteasome inhibitors bortezomib and delanzomib.
    Berkers CR; Leestemaker Y; Schuurman KG; Ruggeri B; Jones-Bolin S; Williams M; Ovaa H
    Mol Pharm; 2012 May; 9(5):1126-35. PubMed ID: 22432738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.
    Sutheesophon K; Kobayashi Y; Takatoku MA; Ozawa K; Kano Y; Ishii H; Furukawa Y
    Acta Haematol; 2006; 115(1-2):78-90. PubMed ID: 16424655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.